microRNAs: Master regulators as potential therapeutics in cancer.
about
mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in micemiRNAs in human cancerCirculating biomarkers to monitor cancer progression and treatmentMicroRNA Regulation of Epithelial to Mesenchymal TransitionEmerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung CancerMicroRNAs - Biology and clinical applicationsAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Mechanisms and role of microRNA deregulation in cancer onset and progressionEGFR-TKI resistance in NSCLC patients: mechanisms and strategiesRepression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24.MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin.miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2.microRNA-200a-3p increases 5-fluorouracil resistance by regulating dual specificity phosphatase 6 expression.Preferential regulation of miRNA targets by environmental chemicals in the human genomePTEN modulates miR-21 processing via RNA-regulatory protein RNH1.Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.miRNAs and cancer: an epigenetics view.MicroRNAs in human cancer.Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated.The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCCGain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samplesmiR-22 represses cancer progression by inducing cellular senescenceMicroRNAs in oligodendrocyte and Schwann cell differentiation.Validation of miRNA-mRNA interactions by electrophoretic mobility shift assays.Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.Apoptotic cell signaling in cancer progression and therapyMiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer.The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cellsOverexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrestMicroRNA-mediated drug resistance in breast cancer.MicroRNA profiling of rats with ochratoxin A nephrotoxicity.A Potential of microRNAs for High-Content ScreeningUpregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
P2860
Q23910476-A4AD0E32-306E-436F-B964-31806557AC00Q24628889-3FAED086-03A0-40AC-9052-54067C31DA4BQ26745985-8F1F3F85-8E08-4C91-A62F-B6DB0F852350Q26771110-E63A6CB1-3E4D-4818-A472-98D703CA1A51Q26798147-B0A6750E-9AA9-4356-874D-813743F324F5Q27024066-B5C74837-EE74-4379-951C-5F938F480A85Q27024427-F5D0D971-8EBB-44EB-94CD-3B2E03820966Q28109709-CCAEF376-28EF-4869-B8EB-2C94F599B0F2Q28394310-FCE9DAE3-34BE-4DEF-BC83-BDA26E2F5A9EQ30571075-62715DA6-D9C8-4020-A3EA-829A7C57BF82Q33568404-5EFF2CF4-716B-4311-BD02-FFCC10B738FBQ33592625-B35DE2C3-30FA-478B-85D7-1DD01B26954EQ33725787-4F09B0C4-2F50-45DD-85F9-00FA6FD27F6BQ33726141-418D8647-AE55-4DFC-B331-D404D8857E19Q33754032-1C31C01B-E3C0-4CEE-A2C5-15040163EA76Q33904808-77D823A5-D4A3-4601-848F-19F2692AC4AAQ34097621-D630CF8B-0316-4A2C-B00D-EA6D96F374B7Q34269452-D78D468D-EB5B-4430-A586-7A1CF6A857E4Q34286618-0815FADF-3720-49DA-B554-75DFCF4B0CFFQ34325959-3DB1075F-07A9-4FED-91B6-532A6977B5B8Q34355656-D148F69F-115E-4269-8E5E-0489D4B3B5F4Q34361840-A5BD0AAA-5B3C-4CBC-A3F5-3470F2B3BD35Q34455481-D51E22FD-AF09-4356-85EC-98517862E088Q34508057-5A77957F-33D2-4A8B-91BE-48C11D95939BQ34669761-90DA77C9-7A70-4E53-A486-A26ED281A894Q34719895-15B015F6-0BC2-40A6-B4D2-718FC846291FQ34763999-9A4CA964-5056-4F13-A823-B420B265F25EQ34825182-330E0D93-FEEC-48DF-8BFD-AE0731DA105CQ34832205-60B237D1-B9D3-4293-950D-7E35D3782CEFQ35038539-41C63EE7-B857-4E8B-A037-CF043A8B52F4Q35082888-1121F11C-768D-4C87-AF72-A24A777AE29AQ35088734-E9FB6FF5-F054-483A-ADC1-DFBA4CB25182Q35099041-1F0F45DE-4AD8-48A5-BC0E-ECA29DD8A5E5Q35111253-553F64A1-1B25-46BF-B7EB-05C4EA57F9D1Q35137424-E5A75E0A-11E3-4076-B9AF-11F442CCE4DCQ35165126-D41050D5-6B33-448E-979B-52C37F18E219Q35178777-96F87DBB-53BB-4EA8-A83A-3C05120C21E7Q35212807-A2309567-B1B6-4F0F-B1E7-9BE570736E35Q35215772-85AD69F9-1D89-4162-84E6-C7DCD19F6AFCQ35781512-7727DEEF-ACC8-4CD8-BE2F-F4B95F2B2B0B
P2860
microRNAs: Master regulators as potential therapeutics in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
microRNAs: Master regulators as potential therapeutics in cancer.
@en
microRNAs: Master regulators as potential therapeutics in cancer.
@nl
type
label
microRNAs: Master regulators as potential therapeutics in cancer.
@en
microRNAs: Master regulators as potential therapeutics in cancer.
@nl
prefLabel
microRNAs: Master regulators as potential therapeutics in cancer.
@en
microRNAs: Master regulators as potential therapeutics in cancer.
@nl
P1476
microRNAs: Master regulators as potential therapeutics in cancer.
@en
P2093
Michela Garofalo
P356
10.1146/ANNUREV-PHARMTOX-010510-100517
P577
2011-01-01T00:00:00Z